Evidence map›Paper›PMID 39508063›Full record

SynthesisPathogens and global health

Dengue virus infection in Saudi Arabia from 2003 to 2023: a systematic review and meta-analysis.

Ali A Rabaan, Amer Alshengeti, Hayam A Alrasheed, Maha F Al-Subaie, Maha H Aljohani, Yahya A Almutawif, Amjad A Yousuf, Shahab A Alsuliman, Jumana M Al-Jishi, Fareed Almalki and 5 more

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Pathogens and global health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ali A RabaanCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Amer AlshengetiDepartment of Pediatrics, College of Medicine, Taibah University, Al-Madinah, Saudi Arabia.
Hayam A AlrasheedDepartment of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Maha F Al-SubaieCollege of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
Maha H AljohaniDepartment of infectious diseases, King Fahad Hospital, Madinah, Saudi Arabia.
Yahya A AlmutawifDepartment of Medical Laboratories Technology, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia.
Amjad A YousufDepartment of Medical Laboratories Technology, College of Applied Medical Sciences, Taibah University, Madinah, Saudi Arabia.
Shahab A AlsulimanInfectious Disease Division, Department of Internal Medicine, Dammam Medical Complex, Dammam, Saudi Arabia.
Jumana M Al-JishiInternal medicine department, Qatif central hospital, Qatif, Saudi Arabia.
Fareed AlmalkiClinical microbiology department, Eradah and Mental Health Complex, Taif, Saudi Arabia.
Maha A AlshiekheidDepartment of Botany and Microbiology, College of Science, King Saud University, Riyadh, Saudi Arabia.
Hejji E AlahmedDepartment of Laboratory and Blood Bank, King Fahad Hospital, Al Hofuf, Saudi Arabia.
Ameen M AlramadanDepartment of Laboratory and Blood Bank, King Fahad Hospital, Al Hofuf, Saudi Arabia.
Safaa Abdulrahman TurkistaniMedical Laboratory Sciences Department, Fakeeh College for Medical Sciences, Jeddah, Saudi Arabia.
Khalid HajissaCenter for Global Health Research, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Chennai, India.ORCID 0000-0002-1725-6702

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dengue virus (DENV) remains one of the most common arboviral infections threatening humans. This study was conducted to systematically review the available literature and provide an updated overview of the overall prevalence of DENV infection in Saudi Arabia. The prevalence data was pooled from 21,891 participants recruited in 17 studies. Using random-effects model, the overall prevalence of DENV infection in Saudi Arabia was calculated as 30.8% (95% CI: 20.8-49.8%). The pooled IgM and IgG seroprevalence rates were 17.7% and 26.6%, respectively. Furthermore, the detection of DENV-NS1 antigen and viral RNA revealed pooled estimates of 16.4% and 37.0%, respectively. This study reports a relatively high burden of DENV infection in Saudi Arabia. The findings of this SRMA provide valuable information on the epidemiology of DENV infections in the country, highlighting the need for additional epidemiological investigations to assess the current situation of DENV infection in the country.

Indexed as

DengueDengue VirusAntibodies, ViralHumansImmunoglobulin GImmunoglobulin MPrevalenceRNA, ViralSaudi ArabiaSeroepidemiologic StudiesAntibodies, ViralImmunoglobulin GImmunoglobulin MRNA, Viraldengue feverDengue virusDENVhemorrhagic feverSaudi Arabia

Identifiers

PMID39508063
PMCPMC11892044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.